Simplex Trading’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20,100
| Closed | -$2K | – | 10176 |
|
|
2024
Q1 | $2K | Sell |
20,100
-5,000
| -20% | -$1.59M | ﹤0.01% | 8508 |
|
|
2023
Q4 | $7.94M | Buy |
25,100
+18,400
| +275% | +$3.58M | 0.01% | 1248 |
|
|
2023
Q3 | $1.13M | Sell |
6,700
-55,200
| -89% | -$10.4M | ﹤0.01% | 2543 |
|
|
2023
Q2 | $13.4M | Sell |
61,900
-15,400
| -20% | -$3.3M | 0.01% | 740 |
|
|
2023
Q1 | $14M | Buy |
77,300
+58,400
| +309% | +$11.2M | 0.01% | 745 |
|
|
2022
Q4 | $3.71M | Sell |
18,900
-7,000
| -27% | -$1.5M | ﹤0.01% | 1413 |
|
|
2022
Q3 | $5.83M | Sell |
25,900
-28,700
| -53% | -$5.81M | 0.01% | 1095 |
|
|
2022
Q2 | $6.91M | Buy |
54,600
+41,300
| +311% | +$4.75M | 0.01% | 962 |
|
|
2022
Q1 | $1.69M | Buy |
13,300
+12,100
| +1,008% | +$1.36M | ﹤0.01% | 2287 |
|
|
2021
Q4 | $157K | Buy |
1,200
+400
| +50% | +$51.7K | ﹤0.01% | 5535 |
|
|
2021
Q3 | $96K | Hold |
800
| – | – | ﹤0.01% | 6677 |
|
|
2021
Q2 | $91K | Buy |
800
+781
| +4,111% | +$91.3K | ﹤0.01% | 6870 |
|
|
2021
Q1 | $228K | Buy |
+19
| New | +$2.15K | ﹤0.01% | 4559 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | -$21K | – | 8572 |
|
|
2020
Q1 | $21K | Buy |
+3
| New | +$257 | ﹤0.01% | 5929 |
|
Simplex Trading's KRTX Position: Q1 2024 in Review
Simplex Trading sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,574 shares — an estimated $1.45M sold.
Simplex Trading first reported a position in KRTX in Q1 2020 and held it in 8 quarters. The position peaked at $1.59M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- Simplex Trading reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 4,574 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.45M.
- Simplex Trading first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
- Simplex Trading's Karuna Therapeutics, Inc. Common Stock position peaked at $1.59M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.